Dh. Kwon et al., Isolation and characterization of tetracycline-resistant clinical isolatesof Helicobacter pylori, ANTIM AG CH, 44(11), 2000, pp. 3203-3205
Tetracycline is an important component of combination therapies for Helicob
acter pylori eradication. Twenty-nine tetracycline-resistant isolates requi
ring MICs ranging from 4 to 16 mug/ml were isolated from Korean (22 of 460)
and Japanese (7 of 105) patients. Interestingly, all of the 29 tetracyclin
e-resistant isolates exhibited cross-resistance to metronidazole, and the c
ross-resistance was transferred to tetracycline-sensitive H. pylori strains
.